Meredith McKean, MD, MPH
Director, Melanoma & Skin Cancer Research
Dr. McKean joined Sarah Cannon in 2018 and serves as director of melanoma & skin cancer research. In her role, Dr. McKean oversees investigational therapy trials for melanoma and other skin cancers.
Dr. McKean received her undergraduate degree from Iowa State University, and her Master of Public Health degree and medical degree from University of Iowa. Prior to joining Sarah Cannon, she completed her fellowship in hematology-oncology at the University of Texas MD Anderson Cancer Center. In 2017, Dr. McKean received an ASCO Conquer Cancer Foundation Young Investigator Award. She is board certified in internal medicine and medical oncology.